Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer immunotherapy for metastasis: past, present and future

13 Jun 2018

Abstract excerpt

Cancer is a complex and refractory disease, which can disseminate from primary site to a different site even at an early stage. Cancer immunotherapy harnesses host immune system to battle against cancer, but only a minority of patients benefit from it. Genetic-based technologies have significantly promoted the development of cancer immunotherapy. Here we describe genetic-based cancer immunotherapies in three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29992233
DOI: 10.1093/bfgp/ely022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer immunotherapy for metastasis: past, present and futurePMID 29992233Read ↗

Advances in cancer immunotherapy: historical perspectives, current developments, and future directionsSemantic proximity Read ↗

Cancer management in the era of immunotherapy: much more than meets the eye.Semantic proximity Read ↗

Adoptive T-Cell Therapy for Cancer.Semantic proximity Read ↗

Strategies for developing and optimizing cancer vaccinesSemantic proximity Read ↗

Adoptive cell transfer as personalized immunotherapy for human cancer.Semantic proximity Read ↗

CAR T cell therapy: newer approaches to counter resistance and costSemantic proximity Read ↗

Cancer immunotherapy: broadening the scope of targetable tumours.Semantic proximity Read ↗

Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.Semantic proximity Read ↗

Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cellsSemantic proximity Read ↗

Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Semantic proximity Read ↗

The Advance Cancer Immunotherapy Techniques and the Future Perspective of Modified T Cell TherapySemantic proximity Read ↗

Adoptive immunotherapy for cancer: the next generation of gene‐engineered immune cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.